OptimizeRx (OPRX)

Doug Besch is the Chief Product Officer and Chief Technology Officer at OptimizeRx since January 1, 2025. " " He previously joined as SVP Product Strategy & Innovation on May 24, 2021 and became Chief Product Officer in October 2022. " " "

Edward Stelmakh serves as CFO and COO at OptimizeRx Corporation since October 11, 2021. He has extensive financial leadership experience, previously holding roles such as CFO at Otsuka America Pharmaceuticals and Covance. " " "

Marion Odence-Ford is the Chief Legal Officer and Chief Human Resources Officer at OPRX since January 1, 2025. " Previously, she served as General Counsel & Chief Compliance Officer starting February 2021. " " "

Theresa Greco has served as Chief Commercial Officer at OPRX since October 2023, after leading Medicx Health as President from August 2022. She has also held executive roles at Prognos Health, MediSpend, LexisNexis Healthcare, and Computer Sciences Corporation. " "

Catherine Klema joined OptimizeRx as a Director and serves as Chair of the Nominating and Governance Committee at OPRX since January 2024. " " " " With over 40 years of experience in healthcare investment, data, and analytics, she has served as President of Nettleton Advisors LLC and held active board roles at Quorum Health, Albert Einstein College of Medicine, and Montefiore Health System. " "

Gregory Wasson joined OptimizeRx Corporation as a Director in July 2020 and serves as a member of the Compensation Committee. He was also nominated for re-election as a director at the 2025 annual stockholders' meeting. " " " " " " "

James Lang has served as Director at OPRX since January 2017, actively guiding board and committee matters such as serving as Compensation Committee Chair and member of the Nominating and Governance Committee. " " " He brings over 30 years of experience in healthcare data and analytics, and he currently holds external roles including CEO at EVERSANA and Executive Advisor at Water Street Healthcare Partners. " " "

Lynn O’Connor Vos joined OptimizeRx as a director in September 2015, became an independent director in 2017, and was appointed Chairperson of the Board of Directors in January 2024, reflecting her extensive expertise in healthcare strategy and corporate governance. " " "

Patrick Spangler joined OPRX as a director in March 2018 and currently serves as the Chair of the Audit Committee. " " " He has over 35 years of finance and healthcare industry expertise, having held key leadership roles such as CFO at multiple companies. " " "